Skip to main content
SpringerLink
Log in

Current Status of Blood and Marrow Transplantation

  • Chapter
Book cover Transplantation in Hematology and Oncology

  • 97 Accesses

Abstract

Bone marrow transplants are increasingly used to treat diverse diseases. Current data from the International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry (ABMTR) indicate >30,000 autografts and >15,000 allografts are done yearly, worldwide. Reasons for increasing use include demonstrated efficacy for hematologic malignancies, bone marrow failure states and congenital immune deficiencies, recent application in solid tumors such as breast cancer, greater availability of donors for allografts and decreased transplant-related morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weiden PL, Sullivan KM, Fluornoy N, et al (1981) Anti-leukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529–1533.

    Article  PubMed  CAS  Google Scholar 

  2. Sullivan KM, Weiden PL, Storb R, et al (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720–1728.

    PubMed  CAS  Google Scholar 

  3. Horowitz MM, Gale RP, Sondel PM, et al (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555–562.

    PubMed  CAS  Google Scholar 

  4. Weiden PL, Flournoy N, Thomas ED, et al (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New Engl J Med 300:1068–1073.

    Article  PubMed  CAS  Google Scholar 

  5. Fefer A, Sullivan KM, Weiden P, et al (1987) Graft versus leukemia effect in man: The relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. In Truitt RL, Gale RP, Bortin MM (eds): Cellular Immunotherapy of Cancer. Alan R. Liss, Inc., New York, NY, pp 401–408.

    Google Scholar 

  6. Gale RP, Horowitz MM, Ash RC, et al (1994) Identical twin bone marrow transplants for leukemia. Ann Intern Med 120:646–652.

    PubMed  CAS  Google Scholar 

  7. Apperley JF, Jones L, Hale G, et al (1986) Bone marrow transplantation for patients with chronic myeloid leukemia: T-cell depletion with Campath-i reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1:53–66.

    PubMed  CAS  Google Scholar 

  8. Butturini A, Gale RP (1987) The role of T-cells in preventing relapse in chronic myelogenous leukemia. Bone Marrow Transplant 2:351–354.

    PubMed  CAS  Google Scholar 

  9. Goldman JM, Gale RP, Horowitz MM, et al (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion. Ann Intern Med 108:806–814.

    PubMed  CAS  Google Scholar 

  10. Marmont AM, Horowitz MM, Gale RP, et al (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120–2130.

    PubMed  CAS  Google Scholar 

  11. Kolb HJ, Mittermüller J, Clemin CH, et al (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462–2465.

    PubMed  CAS  Google Scholar 

  12. Kolb H-J, Schattenberg A, Goldman JM, et al (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041–2050.

    PubMed  CAS  Google Scholar 

  13. Collins RH Jr, Shpilberg O, Drobyski WR, et al (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15:433–444.

    PubMed  Google Scholar 

  14. Jones RJ, Ambinder RF, Piantadosi S, Santos GW (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649–653.

    PubMed  CAS  Google Scholar 

  15. Chopra R, Goldstone AH, Pearce R, et al (1992) Autologous versus allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 10:1690–1695.

    PubMed  CAS  Google Scholar 

  16. Vandenberghe P, Boogaerts MA (1995) Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions. Ann Hematol 71:209–217.

    Article  PubMed  CAS  Google Scholar 

  17. Bensinger WI, Weaver CH, Appelbaum FR, et al (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655–1658.

    PubMed  CAS  Google Scholar 

  18. Körbling M, Przepiorka D, Huh YO, et al (1995) Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659–1665.

    PubMed  Google Scholar 

  19. Schmitz N, Dreger P, Suttorp M, et al (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666–1672.

    PubMed  CAS  Google Scholar 

  20. Schmitz N, Bacigalupo A, Labopin M, et al (1996) Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation. Br J Haematol 95:715–723.

    Article  PubMed  CAS  Google Scholar 

  21. Zhang M-J, Baccarani M, Gale RP, et al (1997) Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. Br J Haematol 99:23–29.

    Article  PubMed  CAS  Google Scholar 

  22. Beelen DW, Graeven U, Elmaagacli AH, et al (1995) Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 85:2981–2990.

    PubMed  CAS  Google Scholar 

  23. Giralt SA, Kantarjian HM, Talpaz M, et al (1993) Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia. J Clin Oncol 11:1055–1061.

    PubMed  CAS  Google Scholar 

  24. Horowitz MM, Giralt S, Szydlo R, et al (1996) Effect of prior interferon therapy on outcome of HLA-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in first chronic phase. Blood 10 (Suppl 1):683a.

    Google Scholar 

  25. Morton AJ, Gooley T, Hansen JA, et al (1997) Impact of pretransplant interferon-alpha on outcome of unrelated donor marrow transplants for chronic myeloid leukemia in first chronic phase. Blood 10 (Suppl 1):123a.

    Google Scholar 

  26. Horning SJ. Autologous hematopoietic cell transplantation for non-Hodgkin’s lymphoma. In: Forman SJ, Blume KG, Thomas ED (eds): Hematopoietic Cell Transplantation. 2nd edition. Blackwell Science, Inc., Boston, MA (in press).

    Google Scholar 

  27. Armitage JO (1994) Bone marrow transplantation. N Engl J Med 330:827–838.

    Article  PubMed  CAS  Google Scholar 

  28. Philip T, Guglielmi C, Hagenbeek A, et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 333:1540–1545.

    Article  PubMed  CAS  Google Scholar 

  29. Haioun C, Lepage E, Gisselbrecht C, et al (1994) Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin’s lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 12:2543–2551.

    PubMed  CAS  Google Scholar 

  30. Haioun C, Lepage E, Gisselbrecht C, et al (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin’s lymphoma: Updated results of the prospective study LNH87–2. J Clin Oncol 15:1131–1137.

    PubMed  CAS  Google Scholar 

  31. Rohatiner AZ, Johnson PW, Price CG, et al (1994) Myeloblative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177–1184.

    PubMed  CAS  Google Scholar 

  32. van Besien KW, de Lima M, Giralt SA, et al (1997) Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant 19:977–982.

    Article  PubMed  Google Scholar 

  33. Lundberg JH, Hansen RM, Chitambar CR, et al (1991) Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. J Clin Oncol 9:1848–1859.

    PubMed  CAS  Google Scholar 

  34. van Besien K, Rowlings PA, Sobocinski KA, et al (1998) Allogeneic bone marrow transplantation for low-grade lymphoma. Blood, in press.

    Google Scholar 

  35. Attal M, Harousseau J-L, Stoppa A-M, et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91–97.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Bone Marrow Transplant Registry, Autologous Blood and Marrow Transplant Registry, Medical College of Wisconsin, P.O. Box 26509, Milwaukee, Wisconsin, 53226, USA

    M. M. Horowitz

Authors
  1. M. M. Horowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine Hematology/Oncology, University of Muenster, Albert-Schweitzer-Straße 33, 48129, Muenster, Germany

    W. E. Berdel (Prof. Dr. med.), Th. Büchner (Prof. Dr. med.), J. Kienast  & J. Van De Loo (Prof. Dr. med.) (Prof. Dr. med.),  (Prof. Dr. med.),  &  (Prof. Dr. med.)

  2. Department of Pediatrics, University of Münster, Albert-Schweitzer-Straße 33, 48129, Muenster, Germany

    H. Jürgens (Prof. Dr. med.), J. Ritter (Prof. Dr. med.) & J. Vormoor (Dr. med.) (Prof. Dr. med.),  (Prof. Dr. med.) &  (Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Horowitz, M.M. (2000). Current Status of Blood and Marrow Transplantation. In: Berdel, W.E., et al. Transplantation in Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59592-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59592-9_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64041-4

  • Online ISBN: 978-3-642-59592-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation